A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


March 24, 2010

Medicare to Cover HIV-Related Facial Wasting Treatment

The Center for Medicare and Medicaid Services (CMS) announced March 23 that it will begin covering the cost of U.S. Food and Drug Administration (FDA)–approved facial wasting (lipoatrophy) treatments for Medicare beneficiaries who have facial lipoatrophy caused by antiretroviral drug use. Effective immediately, CMS will begin covering the cost of facial fillers for people living with HIV who are experiencing symptoms of depression related to the stigmatizing effects of lipoatrophy.

Lipoatrophy is a condition where fat just beneath the skin is lost over time. Lipoatrophy is a side effect caused primarily by the antiretroviral drugs Zerit (stavudine) and Retrovir (zidovudine). Though lipoatrophy can affect any part of the body, it is particularly noticeable and most often stigmatizing when it involves the face.

There are two temporary facial fillers for lipoatrophy: Sculptra (poly-L-lactic acid) and Radiesse (calcium hydroxylapatite). Both cost about $1,500 per application, and people may require treatment more than once per year, a recurrent expense many people with HIV cannot afford.

One of the documented consequences from facial lipoatrophy is depression, brought on because of the stigmatizing nature of facial fat loss. Several studies have shown that treating facial lipoatrophy reduces depressive symptoms in people with HIV.

CMS’s decision “marks an important milestone in Medicare’s coverage for HIV-infection therapies,” said the agency’s chief medical officer and director of its clinical standards and quality. “Helping people living with HIV improve their self-image and comply with anti-HIV treatment can lead to better quality of life and, ultimately, improve the quality of care that beneficiaries receive.”

Search: Medicare, Medicaid, CMS, lipoatrophy, facial wasting, coverage, facial filler, Zerit, stavudine, Retrovir, zidovudine, Sculptra, poly-L-lactic acid, Radiesse, calcium hydroxylapatite

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (29 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.